PLGA LOADED RIFAMPICIN FOR TREAT DIVERSE MYCOBACTERIAL INFECTIONS

  • Unique Paper ID: 165721
  • Volume: 11
  • Issue: 1
  • PageNo: 1454-1457
  • Abstract:
  • The aim of the present work was to minimize or prevent the degradation of rifampicin, the antitubercular drug in gastric pH condition to improve the stability and therapeutic efficacy of the drug. The study was carried out by preparing Rifampicin loaded PLGA nanoparticles using ascorbic acid as an antioxidant. Dug loaded nanoparticles were fabricated by a multistep emulsion procedure and evaluations of the prepared nanoparticles were then carried out by various methods. In this study four types of formulations were prepared. Formulation 1 (F1) is rifampicin alone loaded PLGA nanoparticles, formulation II (F2) is rifampicin – ascorbic acid (1:1) loaded PLGA nanoparticles, formulation III (F3) is rifampicin - ascorbic acid (1:2) loaded PLGA nanoparticles and formulation IV (F4) is rifampicin – ascorbic acid (1:3) loaded PLGA nanoparticles. The study concluded that ascorbic acid can minimize the degradation of rifampicin in acidic pH condition and thus improves the stability and bioavailability of rifampicin. The results also demonstrate that there is a statistically significant change in the percentage drug degradation profile when the concentration of ascorbic acid was increased.

Copyright & License

Copyright © 2025 Authors retain the copyright of this article. This article is an open access article distributed under the Creative Commons Attribution License which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

BibTeX

@article{165721,
        author = {Meena Bandiya and Rohit Yadav and Garima Carpenter and Darshan Dubey},
        title = {PLGA LOADED RIFAMPICIN FOR TREAT DIVERSE MYCOBACTERIAL INFECTIONS},
        journal = {International Journal of Innovative Research in Technology},
        year = {},
        volume = {11},
        number = {1},
        pages = {1454-1457},
        issn = {2349-6002},
        url = {https://ijirt.org/article?manuscript=165721},
        abstract = {The aim of the present work was to minimize or prevent the degradation of rifampicin, the antitubercular drug in gastric pH condition to improve the stability and therapeutic efficacy of the drug. The study was carried out by preparing Rifampicin loaded PLGA nanoparticles using ascorbic acid as an antioxidant. Dug loaded nanoparticles were fabricated by a multistep emulsion procedure and evaluations of the prepared nanoparticles were then carried out by various methods. In this study four types of formulations were prepared. Formulation 1 (F1) is rifampicin alone loaded PLGA nanoparticles, formulation II (F2) is rifampicin – ascorbic acid (1:1) loaded PLGA nanoparticles, formulation III (F3) is rifampicin - ascorbic acid (1:2) loaded PLGA nanoparticles and formulation IV (F4) is rifampicin – ascorbic acid (1:3) loaded PLGA nanoparticles. The study concluded that ascorbic acid can minimize the degradation of rifampicin in acidic pH condition and thus improves the stability and bioavailability of rifampicin. The results also demonstrate that there is a statistically significant change in the percentage drug degradation profile when the concentration of ascorbic acid was increased.},
        keywords = {PLGA, Nanoparticles, Antitubercular, Rifampicin, Ascorbic Acid, Bioavailability},
        month = {},
        }

Cite This Article

  • ISSN: 2349-6002
  • Volume: 11
  • Issue: 1
  • PageNo: 1454-1457

PLGA LOADED RIFAMPICIN FOR TREAT DIVERSE MYCOBACTERIAL INFECTIONS

Related Articles